natgillin/translations-raw huggingface dataset:
272 raise or lower your dose, or interrupt your treatment according to the test results.
Vaš odmerek vam lahko glede na rezultat krvnih preiskav zviša ali zniža ali zdravljenje prekine.
The haemoglobin values should not exceed a value of 12 g/dL.
Koncentracija hemoglobina ne sme preseči 12 g/ dl.
• People donating their own blood before surgery
• Osebe, ki darujejo svojo kri pred operacijo
Injections are given into a vein over two minutes, or under the skin.
Injekcije dajemo v veno približno 2 minuti ali pod kožo.
The maximum dose should not exceed • for injections into veins:
Največji odmerek ne sme preseči: • pri injekcijah v veno:
1600 IU for every 1 kg of your body weight per week • for injections under the skin:
1600 i. e. / kg telesne mase na teden, • pri podkožnem injiciranju:
1200 IU for every 1 kg of your body weight per week.
1200 i. e. / kg telesne mase na teden.
If you inject too much NeoRecormon Do not increase the dose your doctor has given you.
Če ste injicirali prevelik odmerek zdravila NeoRecormon Odmerka, ki vam ga je predpisal zdravnik, ne povečujte.
If you think you have injected more NeoRecormon than you should, contact your doctor.
Če mislite, da ste si injicirali več zdravila NeoRecormon, kot bi smeli, obvestite svojega zdravnika.
If you forget to take NeoRecormon If you have missed an injection, or injected too little, talk to your doctor.
Če ste pozabili vzeti zdravilo NeoRecormon Če ste izpustili injekcijo ali ste si injicirali premajhen odmerek, se posvetujte s svojim zdravnikom.
Like all medicines, NeoRecormon can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo NeoRecormon neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Side effects which can affect any patient • Most people get lower levels of iron in their blood.
Neželeni učinki, ki lahko prizadenejo vse bolnike • Pri večini bolnikov pride do zmanjšanja koncentracij železa v krvi.
Almost all patients have to be treated with iron supplements during their NeoRecormon therapy. • Rarely, allergies or skin reactions, such as rash or hives, itching or reactions around the injection site have occurred. • Very rarely a severe form of allergic reaction has occurred, especially just after an injection.
Skoraj vse bolnike je med zdravljenjem z zdravilom NeoRecormon treba zdraviti z nadomestki železa. • Redko so se pojavile alergije ali kožne reakcije, kot kožni izpuščaj ali koprivnica, srbenje ali reakcije okoli mesta injiciranja. • Zelo redko se je, še posebno takoj po injekciji, pojavila huda oblika alergijske reakcije.
If you get unusual wheezing or difficulty breathing; swollen tongue, face or throat, or swelling around the injection site; if you feel lightheaded or faint or if you collapse, call your doctor at once. • Very rarely people experienced flu-like symptoms, especially when they just started treatment.
Če se pri vas pojavijo nenavadno sopenje ali težave z dihanjem, otečen jezik, obraz ali vrat ali oteklina na mestu injiciranja, če se počutite omotično ali slabotno ali če se zgrudite, takoj pokličite svojega zdravnika. • Zelo redko so se pri bolnikih pojavili gripi podobni simptomi, še posebno, če so z zdravljenjem komaj začeli.
These include fever, chills, headaches, pain in the limbs, bone pain and/or feeling generally unwell.
To vključuje zvišano telesno temperaturo, mrzlico, glavobole, bolečino v udih, bolečino v kosteh in/ ali splošno slabo počutje.
273 Additional side effects in people with chronic kidney disease (renal anaemia) • Increase in blood pressure, worsening of existing high blood pressure and headache are the most common side effects.
276 Dodatni neželeni učinki pri bolnikih s kronično ledvično boleznijo (ledvična anemija) • Zvišanje krvnega tlaka, poslabšanje obstoječega zvišanega krvnega tlaka in glavobol so najpogostejši neželeni učinki.
These may be signs of severely elevated blood pressure (hypertensive crisis), even if your blood pressure is usually normal or low.
Morda bo zvišan krvni tlak zdravil z zdravili ali pa bo začasno prekinil zdravljenje z zdravilom NeoRecormon. • Takoj pokličite zdravnika, če se pojavi glavobol, še posebno nenaden, zbadajoč glavobol, podoben migrenskemu, stanje zmedenosti, motnje govora, nestabilna hoja, krči ali konvulzija. To so lahko znaki zelo povišanega krvnega tlaka (hipertenzivne krize), čeprav je vaš krvni tlak običajno normalen ali nizek.
It needs to be treated at once. • If you have low blood pressure or shunt complications you may be at risk of shunt thrombosis (a blood clot in the vessel used for connection to the dialysis system). • Very rarely, patients have had rising levels of potassium or phosphates in the blood.
Potrebujete takojšnjo zdravniško pomoč. • Če imate nizek krvni tlak ali zaplete s spojem, imate lahko povečano tveganje za obvodno trombozo (krvni strdek v cevki za povezavo z dializnim sistemom). • Zelo redko so se pri bolnikih pojavile povečane koncentracije kalija ali fosfatov v krvi.
This can be treated by your doctor. • Pure red cell aplasia (PRCA) caused by neutralising antibodies has been observed during erythropoietin therapy, including in isolated cases during therapy with NeoRecormon.
To lahko vaš zdravnik pozdravi. • Med zdravljenjem z eritropoetinom, vključno v posameznih primerih med zdravljenjem z zdravilom NeoRecormon, je bila opažena čista aplazija rdečih krvnih celic (PRCA - pure red cell aplasia), ki jo povzročajo nevtralizirajoča protitelesa.
Additional side effects in adults receiving chemotherapy for cancer • Increase in blood pressure and headache may occasionally occur.
Dodatni neželeni učinki pri odraslih, ki prejemajo kemoterapijo zaradi raka • Zvišanje krvnega tlaka in glavobol se lahko pojavita občasno.
Your doctor may treat the high blood pressure with drugs. • An increase in the occurrence of blood clots has been observed.
Vaš zdravnik bo lahko zdravil visok krvni tlak z zdravili. • Opazili so porast v pojavu krvnih strdkov.
Additional side effects in people donating their own blood before surgery • A slight increase in the occurrence of blood clots has been observed.
Dodatni neželeni učinki pri osebah, ki darujejo svojo kri pred operacijo: • Opazili so rahel porast v pojavu krvnih strdkov.
HOW TO STORE NEORECORMON
SHRANJEVANJE ZDRAVILA NEORECORMON
• Keep out of the reach and sight of children. • Do not use NeoRecormon after the expiry date which is stated on the pack. • Store in a refrigerator (2°C – 8°C). • The vial can be removed from the refrigerator and left at room temperature for a single period of maximum 5 days (but not above 25°C). • The reconstituted solution may be stored for 1 month in a refrigerator at 2°C – 8°C. • Keep the container in the outer carton in order to protect from light. • Medicines should not be disposed of via wastewater or household waste.
• Zdravilo shranjujte nedosegljivo otrokom! • Zdravila NeoRecormon ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini. • Shranjujte v hladilniku (2 °C – 8 °C). • Vialo lahko vzamemo iz hladilnika in jo nato hranimo pri sobni temperaturi (do 25 ºC), vendar le enkrat in za največ 5 dni. • Pripravljeno raztopino lahko hranimo v hladilniku pri 2 °C – 8 °C do 1 meseca. • Vsebnik shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo. • Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
- The active substance is epoetin beta.
- Zdravilna učinkovina je epoetin beta.
One vial contains either 50,000 IU or 100,000 IU
Ena viala vsebuje 50. 000 i. e. ali 100. 000 i. e.
(international units) epoetin beta.
(mednarodnih enot) epoetina beta.
- The other ingredients are urea, sodium chloride, polysorbate 20, sodium dihydrogen phosphate,
277
disodium hydrogen phospate, calcium chloride, glycine, L-Leucine, L-Isoleucine, L-Threonine, L-Glutamic acid, and L-Phenylalanine.
- Pomožne snovi so sečnina, natrijev klorid, polisorbat 20, natrijev dihidrogenfosfat, natrijev
274
hidrogenfosfat, kalcijev klorid, glicin, L- levcin, L- izolevcin, L- treonin, L- glutaminska kislina in L- fenilalanin.
- The solvent contains benzyl alcohol and benzalkonium chloride as preservatives in 10 ml (for
- Vehikel vsebuje benzilalkohol in benzalkonijev klorid kot konzervansa v 10 ml (za
the NeoRecormon Multidose 50,000 IU) or 5 ml (for the NeoRecormon Multidose 100,000 IU) water for injections.
NeoRecormon 50. 000 i. e. za večodmerno raztopino za injiciranje) ali 5 ml (za NeoRecormon 100. 000 i. e. za večodmerno raztopino za injiciranje) vode za injekcije.
White lyophilisate and clear, colourless solvent
Bel liofilizat in bister, brezbarven vehikel.
NeoRecormon Multidose is provided as a lyophilisate vial and solvent ampoule for solution for injection.
Večodmerno zdravilo NeoRecormon je na voljo kot liofilizat v viali in vehikel v ampuli za raztopino za injiciranje.
Manufacturer Roche Diagnostics GmbH Sandhofer Str.
Izdelovalec Roche Diagnostics GmbH Sandhofer Str.
116 68305 Mannheim Germany
116 68305 Mannheim Nemčija
Τηλ: +30 210 61 66 100
278 Polska Ελλάδα Roche Polska Sp. z o. o.
INFORMATION FOR THE USER
279 NAVODILO ZA UPORABO
NeoRecormon 10,000 IU NeoRecormon 20,000 IU NeoRecormon 60,000 IU Lyophilisate and solvent for solution for injection in cartridge Epoetin beta
NeoRecormon 60. 000 i. e. liofilizat in vehikel za raztopino za injiciranje v vložku epoetin beta
please tell your doctor of pharmacist.
omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
NeoRecormon cartridge is a two-chamber cartridge containing white lyophilisate and solvent.
Vložek zdravila NeoRecormon je dvoprekatni vložek, ki vsebuje bel liofilizat in vehikel.
After dissolving, NeoRecormon is injected under the skin (subcutaneously).
Po raztopitvi zdravilo NeoRecormon injiciramo pod kožo (subkutano).
• Treating symptomatic anaemia caused by chronic kidney disease (renal anaemia) in patients on dialysis, or not yet on dialysis. • Treating anaemia with related symptoms in adult cancer patients receiving chemotherapy • Treating people donating their own blood before surgery.
• zdravljenje simptomatske anemije, povzročene s kronično ledvično boleznijo (ledvična anemija) pri bolnikih, ki so na dializi ali se še ne zdravijo z dializo; • zdravljenje anemije s podobnimi simptomi pri odraslih bolnikih z rakom, ki prejemajo kemoterapijo; • zdravljenje bolnikov, ki pred operacijo darujejo kri.
Do not use NeoRecormon: • if you are allergic (hypersensitive) to epoetin beta or any of the other ingredients of NeoRecormon or benzoic acid, a metabolite of benzyl alcohol • if you have blood pressure problems that cannot be controlled • if you are donating your own blood before surgery, and:
Ne uporabljajte zdravila NeoRecormon: • če ste alergični na (preobčutljivi za) epoetin beta ali katerokoli sestavino zdravila NeoRecormon ali benzojsko kislino, presnovek benzilalkohola; • če imate težave s krvnim tlakom, ki jih ni mogoče nadzorovati; • če pred operacijo darujete kri in
– – –
280
you had a heart attack or stroke in the month before your treatment you have unstable angina pectoris – new or increasing chest pain you are at risk of blood clots in the veins (deep venous thrombosis) – for example, if you have had clots before.
če pri vas obstaja tveganje za nastanek krvnih strdkov v venah (globoke venske tromboze) – na primer, če ste imeli krvne strdke že v preteklosti;
277 • in infants or young children up to 3 years, since NeoRecormon in cartridge contains benzyl alcohol as a preservative If any of these apply to you, or might apply, tell your doctor at once.
Če se karkoli izmed naštetega nanaša ali bi se lahko nanašalo na vas, se takoj posvetujte s svojim zdravnikom.
If you have high or rising potassium levels your doctor may reconsider your treatment • your blood platelet count.
Če bodo koncentracije kalija previsoke ali bodo naraščale, bo zdravnik ponovno pretehtal vaše zdravljenje; • koncentracije vaših trombocitov.
Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
281 Jemanje drugih zdravil Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
278 Pregnancy and breast-feeding There is not much experience with NeoRecormon in pregnant women or women who are breast- feeding.
Nosečnost in dojenje O uporabi zdravila NeoRecormon pri nosečnicah in doječih ženskah ni ustreznih izkušenj.
Important information about some of the ingredients of NeoRecormon This medicine contains phenylalanine.
Pomembne informacije o nekaterih sestavinah zdravila NeoRecormon To zdravilo vsebuje fenilalanin.
NeoRecormon cartridge should only be used with Reco-Pen.
Zdravilo NeoRecormon v vložku lahko uporabljamo le z Reco- Penom.
Remove one cartridge from the pack,
Iz ovojnine vzemite en vložek.
Remove a needle from the pack and fix it securely on the Reco-Pen,
Iz ovojnine vzemite injekcijsko iglo in jo varno pritrdite na Reco- Pen.
Insert the cartridge into the Reco-Pen,
Vložek vstavite v Reco- Pen.
Press the cartridge to dissolve the lyophilisate in the solvent Check the solution in the cartridge:
Preverite, ali je raztopina v vložku:
• • • If the
• • • Če je
is it clear? is it colourless? is it free of particles? answer is NO to any question, do not administer the injection.
bistra, brezbarvna, brez vidnih delcev. na katero izmed zgornjih lastnosti odgovor NE, raztopine ne injicirajte.
Dispose of it and start again with a different cartridge.
Vložek zavrzite in ponovno začnite postopek z novim vložkom.
If you answer yes to all three, remove the cap from the Reco-Pen and go to step 5.
Če odgovorite na vsa tri vprašanja z da, odstranite zaporko z Reco- Pena in pojdite na korak 5.
Expel air from the cartridge and needle.
Odstranite zrak iz vložka in injekcijske igle.
Do this by lightly tapping on the upper half of the Reco-Pen.
To storite z rahlim trkanjem na zgornjo polovico Reco- Pena.
Then hold the Reco-Pen vertically and the needle upwards, and gently push the plunger upwards.
Reco- Pen držite v navpičnem položaju z injekcijsko iglo navzgor ter nato rahlo pritisnite bat navzgor.
Keep pushing the plunger until the amount of NeoRecormon in the Reco-Pen is as prescribed.
Bat potiskajte toliko časa, dokler količina zdravila NeoRecormon v Reco- Penu ni enaka predpisani.
Clean the skin at the injection site using an alcohol wipe.
Kožo na mestu injiciranja očistite z alkoholno krpico.
Holding the Reco-Pen near the needle, insert the needle into the skin fold with a quick, firm action.
Reco- Pen primite blizu igle in vstavite iglo v kožno gubo s hitrim in odločnim vbodom.
NeoRecormon dosing The dose of NeoRecormon depends on your dise ase condition, the way the injection is given (under the skin) and your body weight.
282 Odmerjanje zdravila NeoRecormon Odmerek zdravila NeoRecormon bo odvisen od stanja vaše bolezni, načina dajanja injekcije (pod kožo) in vaše telesne mase.
279 • Symptomatic anaemia caused by chronic kidney disease
• Simptomatska anemija zaradi kronične ledvične bolezni
a) Correcting the anaemia The initial dose is 20 IU per injection for every 1 kg of your body weight, given three times per week.
a) Popravljanje anemije Začetni odmerek je 20 i. e. / kg telesne mase, dano trikrat na teden.
The maximum dose should not exceed 720 IU for every 1 kg of your body weight per week.
Največji odmerek ne sme preseči 720 i. e. / kg telesne mase na teden.
However, it can be interrupted at any time, if necessary.
Običajno je zdravljenje z zdravilom NeoRecormon dolgotrajno, vendar ga lahko kadarkoli prekinemo, če je treba.
Your doctor may initiate treatment with NeoRecormon if your haemoglobin level is 10 g/dL or less.
Vaš zdravnik lahko uvede zdravljenje z zdravilom NeoRecormon, če je vaša koncentracija hemoglobina 10 g/ dl ali manj.
The maximum dose should not exceed •1200 IU for every 1 kg of your body weight per week.
283 • 1200 i. e. / kg telesne mase na teden.
280 If you forget to take NeoRecormon If you have missed an injection, or injected too little, talk to your doctor.
Če ste pozabili vzeti zdravilo NeoRecormon Če ste izpustili injekcijo ali ste si injicirali premajhen odmerek, se posvetujte s svojim zdravnikom.
If you have any further questions on the use of this product, as your doctor or pharmacist.
Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom ali s farmacevtom.
These include fever, chills, headaches, pain in the limbs, bone pain and/or feeling generally unwell.
To vključuje zvišano telesno temperaturo, mrzlico, glavobol, bolečino v udih, bolečino v kosteh in/ ali splošno slabo počutje.
Additional side effects in people with chronic kidney disease (renal anaemia) • Increase in blood pressure, worsening of existing high blood pressure and headache are the most common side effects.
Dodatni neželeni učinki pri bolnikih s kronično ledvično boleznijo (ledvična anemija) • Zvišanje krvnega tlaka, poslabšanje obstoječega zvišanega krvnega tlaka in glavobol so najpogostejši neželeni učinki.
Your doctor may treat the high blood pressure with drugs or temporarily interrupt your NeoRecormon therapy. • Call a doctor at once if you get headaches, especially sudden, stabbing, migraine-like headaches, confusion, speech disturbance, unsteady walking, fits or convulsions.
• Takoj pokličite zdravnika, če se pojavi glavobol, še posebno nenaden, zbadajoč glavobol, podoben migrenskemu, stanje zmedenosti, motnje govora, nestabilna hoja, krči ali konvulzija.
Additional side effects in adults receiving chemotherapy for cancer • Increase in blood pressure and headache may occasionally occur.
284 Dodatni neželeni učinki pri odraslih, ki prejemajo kemoterapijo zaradi raka • Zvišanje krvnega tlaka in glavobol se lahko pojavita občasno.
• Keep out of the reach and sight of children. • Do not use NeoRecormon after the expiry date which is stated on the pack. • Keep the cartridge in the outer carton, in order to protect from light. • Store in a refrigerator (2°C – 8°C). • The cartridge not yet inserted into the Reco-Pen can be removed from the refrigerator and left at room temperature for a single period of maximum 5 days (but not above 25°C). • After insertion into the Reco-Pen the cooling chain may only be interrupted for injecting the product. • The dissolved solution may be stored for 1 month in a refrigerator at 2°C – 8°C. • Medicines should not be disposed of via wastewater or household waste.
• Zdravilo shranjujte nedosegljivo otrokom! • Zdravila NeoRecormon ne smete uporabljati po datumu izteka uporabnosti, ki je naveden na ovojnini. • Shranjujte vložek v zunanji ovojnini za zagotovitev zaščite pred svetlobo. • Shranjujte v hladilniku (2 °C – 8 °C). • Vložek, ki še ni vstavljen v Reco- Pen lahko vzamete iz hladilnika in ga nato hranite pri sobni temperaturi (do 25 ºC), vendar le enkrat in za največ 5 dni. • Po vstavitvi v Reco- Pen lahko hladilno verigo prekinemo le za injiciranje zdravila. • Pripravljeno raztopino lahko v hladilniku hranite 1 mesec pri temperaturi med 2 °C do 8 °C. • Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
One cartridge contains either 10,000 IU, 20,000 IU or
En vložek vsebuje 10. 000 i. e., 20. 000 i. e. ali 60. 000 i. e.
60,000 IU (international units) epoetin beta.
(mednarodnih enot) epoetina beta.
- The other ingredients are urea, sodium chloride, polysorbate 20, sodium dihydrogen phosphate,
- Pomožne snovi so sečnina, natrijev klorid, polisorbat 20, natrijev dihidrogenfosfat, natrijev
disodium hydrogen phospate, calcium chloride, glycine, L-Leucine, L-Isoleucine, L-Threonine, L-Glutamic acid, and L-Phenylalanine.
hidrogenfosfat, kalcijev klorid, L- glicin, L- levcin, L- izolevcin, L- treonin, L- glutaminska kislina in L- fenilalanin.
- The solvent contains benzyl alcohol and benzalkonium chloride as preservatives in 1 ml water
- Vehikel vsebuje benzilalkohol in benzalkonijev klorid kot konzervansa v 1 ml vode za injekcije.
NeoRecormon is provided as a lyophilisate and solvent for solution for injection in cartridge.
Zdravilo NeoRecormon je na voljo kot liofilizat in vehikel za raztopino za injiciranje v vložku.
Pack size of 1, or 3.
Pakiranje po 1 ali 3.
Manufacturer Roche Diagnostics GmbH Sandhofer Str.
285 Izdelovalec Roche Diagnostics GmbH Sandhofer Str.
282 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:
Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom:
Italia Roche S.p.A.
286 Italia Roche S. p. A.
INFORMATION FOR THE USER
287 NAVODILO ZA UPORABO
NeoRecormon 500 IU NeoRecormon 1,000 IU NeoRecormon 2,000 IU NeoRecormon 3,000 IU NeoRecormon 4,000 IU NeoRecormon 5,000 IU NeoRecormon 6,000 IU NeoRecormon 10,000 IU NeoRecormon 20,000 IU NeoRecormon 30,000 IU Solution for injection in pre -filled syringe Epoetin beta
NeoRecormon 30. 000 i. e. raztopina za injiciranje v napolnjeni injekcijski brizgi epoetin beta
NeoRecormon injections are used for:
Injekcije NeoRecormon uporabljamo za:
• Treating symptomatic anaemia caused by chronic kidney disease (renal anaemia) in patients on dialysis, or not yet on dialysis. • Preventing anaemia in premature infants (weighing 750 to 1500 g and born at less than 34 weeks). • Treating anaemia with related symptoms in adult cancer patients receiving chemotherapy • Treating people donating their own blood before surgery.
• zdravljenje simptomatske anemije, povzročene s kronično ledvično boleznijo (ledvična anemija) pri bolnikih, ki so na dializi ali se še ne zdravijo z dializo; • preprečevanje anemije pri nedonošenčkih (ki tehtajo 750 do 1500 g in so rojeni pri manj kot 34. tednih); • zdravljenje anemije in njenih simptomov pri odraslih bolnikih z rakom, ki prejemajo kemoterapijo; • zdravljenje bolnikov, ki pred operacijo darujejo kri.
Do not use NeoRecormon: • if you are allergic (hypersensitive) to epoetin beta or any of the other ingredients of NeoRecormon • if you have blood pressure problems that cannot be controlled • if you are donating your own blood before surgery, and:
Ne uporabljajte zdravila NeoRecormon: • če ste alergični na (preobčutljivi za) epoetin beta ali katerokoli sestavino zdravila NeoRecormon ali benzojsko kislino, presnovek benzilalkohola; • če imate težave s krvnim tlakom, ki jih ni mogoče nadzorovati; • če pred operacijo darujete kri in
you had a heart attack or stroke in the month before your treatment you have unstable angina pectoris – new or increasing chest pain you are at risk of blood clots in the veins (deep venous thrombosis) – for example, if you have had clots before.
če ste v preteklem mesecu doživeli miokardni infarkt ali kap, če imate nestabilno angino pektoris – novo ali naraščajočo bolečino v prsnem košu, če pri vas obstaja tveganje za nastanek krvnih strdkov v venah (globoke venske tromboze) – na primer, če ste imeli krvne strdke že v preteklosti.
If any of these apply to you, or might apply, tell your doctor at once.
Če se kar koli izmed naštetega nanaša ali bi se lahko nanašalo na vas, se takoj posvetujte s svojim zdravnikom.
Take special care with NeoRecormon: • if your anaemia does not improve with epoetin treatment • if you are low in certain B vitamins (folic acid or vitamin B12) • if you have very high levels of aluminium in your blood • if your blood platelet count is high • if you have chronic liver disease • if you have epilepsy • if you have developed anti-erythropoietin antibodies and pure red cell aplasia (reduced or stopped production of red blood cells) during prior exposure to any erythropoietic substance.
Bodite posebno pozorni pri uporabi zdravila NeoRecormon: • če se vaša anemija ne popravi po zdravljenju z epoetinom, • če imate nizke koncentracije določenih vitaminov B (folne kisline ali vitamina B12), • če imate zelo visoko koncentracijo aluminija v krvi, • če imate visoko koncentracijo trombocitov, • če imate kronično jetrno bolezen, • če imate epilepsijo, • če so se pri vas pojavila protitelesa proti eritropoetinu in čista aplazija rdečih krvnih celic (zmanjšano ali ustavljeno nastajanje rdečih krvnih telesc) med prejšnjim prejemanjem katere koli oblike eritropoetina.
If any of these apply to you, tell your doctor.
Če se kar koli izmed naštetega nanaša na vas, se takoj posvetujte s svojim zdravnikom.